Ar­genx pod­cast se­ries fo­cused on a rare dis­ease draws wide au­di­ence amid plans for sec­ond sea­son

It turns out that maybe rare isn’t so rare when it comes to pod­casts.

Ar­genx says its myas­the­nia gravis-fo­cused pod­cast cur­rent­ly ranks in the top …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA